The major AI companies are paying substantial sums for real-world data to train their models. Depending on the buyer, that is a non-exclusive licence you can place again and again, or a one-time exclusive buyout. We tell you which applies before you commit to anything.
No licensee ever sees real identities. De-identification is done by an independent specialist before anything is handed over — inside your own environment or in a secure processing environment, depending on the route. The licensee only ever receives de-identified material, to a documented and independently reviewed standard.
What you hold, roughly how much, and where your rights stand.
System names, volumes and years of history. Never messages or files. You get a realistic range.
You set what is in and what is out. Licence or buyout is clear before you sign.
A one-time historical export, run by your team or with its sign-off. Nothing is left connected.
An independent specialist removes identity, to a reviewed standard, before any licensee sees anything.
The licensee receives de-identified material only. You are paid under the agreement.
licensemycompanydata.com explains how AI companies license email, chat, documents, CRM, finance, tickets and code, compares the buyers that pay companies directly, and sends you straight to the ones that fit.
A licence for machine-learning training. Ownership never transfers, and every other right you hold stays with you.
A non-exclusive licence is usually the better deal: your material stays available, so it can be placed with several buyers and you are paid on each. A one-time exclusive buyout is the alternative, and sometimes the right call. We will tell you which is on the table.
Training data is consumed by a model — never aired, streamed or resold. Far narrower rights than you are used to negotiating.
We are paid out of the transaction, by the processor or licensee, never by you. No charge to qualify, no commitment. If an introducer brought you, any fee is between you and them.
The window in which frontier models are projected to fully use up the world's stock of public human-written text.
Epoch AI, 2024 (80% confidence interval)
Of enterprise applications expected to carry task-specific AI agents by the end of 2026, up from under 5% in 2025.
Gartner, August 2025
Of day-to-day work decisions expected to be made autonomously by 2028, up from effectively none in 2024.
Gartner, June 2025
Public text taught models language. It does not show how real work is done. It does not show how a clinician reasons through a case, or how a finished film is shot and cut. Real-world records and footage do — which is why they now have a price.
For hospital and clinic groups, telehealth platforms, EHR vendors, scribe services and CROs.
Licensees want real clinical material with documented consent covering training use. Demand is worldwide, and records from outside North America and Europe are actively in review. It does not need to arrive de-identified — the processor handles that where you cannot.
Whether records can lawfully leave their country is established before anything moves. We will tell you plainly if the answer is no.
Consent must be documented, not asserted. The processor can de-identify records; it cannot create permission that was never captured. Expect to produce the paperwork — consent form, IRB approval, data-use agreement, or your jurisdiction's equivalent.
The standard is local. Expert determination under HIPAA for US records; elsewhere the local regime — DPDP in India, PDPL in Saudi Arabia, POPIA in South Africa, PIPA in South Korea. Most of what we see is not US-origin, so HIPAA is often not the test.
Our role depends on the deal. For some clinical data we take a licence ourselves and sublicense it, so we are a party to your agreement. In other cases we introduce you to the processor directly. We tell you which before you sign, and we never hold the records ourselves.
Longitudinal case packs. One de-identified patient over multiple time periods — notes, imaging, diagnosis, outcomes. Imaging is the strongest addition; complex cases over longer periods are the most wanted.
Records at scale. Single-visit records in volume from an EHR or HIS. Breadth over depth; non-English qualifies.
Visit transcripts. Consultations, telehealth or in-office, any language. Worth materially more with the clinician's note and record entry attached.
Consultation video. In-office or telehealth, recorded anywhere under Western clinical practice.
An archive that earns more than once — if it is the right archive.
For animation studios, producers, and film and television rights holders.
The market has changed. Through 2024 buyers took large volumes of general footage for pre-training. That has largely stopped, and rates across general video have compressed sharply. What still sells — and sells well — is finished, cinematic-quality work that cannot be found in public datasets.
So we would rather tell you plainly what is wanted than take an archive that will sit unplaced. If what you hold is below, there is active demand. If it is not, we will say so rather than ingest it.
You need the rights to license for this purpose. Old contracts often grant broadcast or distribution while saying nothing about training use, and silence is not permission. Unsure is a normal starting point.
Production companies: your business records are a separate matter. Email, project history, finance and contracts are licensed as company data. See licensemycompanydata.com.
The strongest category in the market and the best rates we are seeing. Any style, any length, finished and rights-clear.
Finished feature film, scripted series and high-end documentary, shot to cinematic quality and rights-clear.
Other material may be considered, especially if it is unique and cannot be found in public datasets. Tell us what you hold and we will say plainly whether there is demand.
What makes an archive attractive: clean, documented rights above everything else; unedited long-form over short polished cuts; consistent technical quality; coherent labelling; and the production material that goes with it — scripts, storyboards, edit decision lists. Raw, unaired and B-roll is often the most valuable part, because it was never published and the rights sit in one pair of hands.
When a business closes, what it holds does not stop being valuable. Clinical records and film, television or animation libraries are assets of the estate — and in most wind-downs nobody has counted them as one. For the email, chat and documents of a closed company, see closing a company on licensemycompanydata.com.
These move faster than ordinary corporate conversations. There is no competitive position left to protect, the decision-maker is identifiable, and there is usually a deadline that concentrates everyone.
Trustees, administrators, liquidators, wind-down officers and counsel to any of them — as well as founders closing a company themselves, and acquirers left holding legacy systems after a carve-out.
Customer contracts, NDAs and privacy obligations often survive the company. Establishing what can lawfully be licensed is the first work done, and we will tell you plainly if the answer is nothing.
Licensing an estate asset usually needs approval, and we work alongside your counsel rather than around them.
If you know clinic groups, telehealth platforms or holders of film and animation archives, bring them to us. Introducing companies with business data? See the partner programme on licensemycompanydata.com. We share commission on transactions you originate, under a written agreement covering origination, split and non-circumvention.
No cost, no exclusivity, no volume commitment. Get in touch for terms.
A short call to establish what you hold and where your rights position stands. No cost, no commitment.
There is also a short valuation assessment that returns an indicative range for what you hold. We send you the link after that first conversation, once your enquiry is registered to you.
Licensing company records — email, chat, documents, CRM? Start at licensemycompanydata.com.